Andreas KJAER,Ulrich KNIGGE,Liselotte HØJGAARD,Palle RASMUSSEN
申请号：
US16454631
公开号：
US20190321497A1
申请日:
2019.06.27
申请国别(地区):
US
年份:
2019
代理人:
摘要：
There is provided a radiolabelled peptide-based compound for diagnostic imaging using positron emission tomography (PET). The compound may thus be used for diagnosis of malignant diseases. The compound is particularly useful for imaging of somatostatin overexpression in tumors, wherein the compound is capable of being imaged by PET when administered with a target dose in the range of 150-350 MBq, such as 150-250 MBq, preferable in the range of 191-210 MBq.
